Biothera to Introduce Wellmune WGP at the Institute of Food Technologists 2007 Annual Meeting & Food Expo

EAGAN, MN – July 26, 2007 – Biothera will introduce Wellmune WGP(R) , a natural functional food and beverage ingredient clinically proven to enhance key immune responses, at the Institute of Food Technologists’ (IFT) 2007 Annual Meeting & Food Expo July 28-August 1 in Chicago. Biothera’s IFT booth is #4227.

Wellmune WGP engages the body’s natural defenses to promotes health, wellness and vitality. Numerous clinical and preclinical studies demonstrate that Wellmune WGP activates key human immune cells, including macrophages and neutrophils, to more quickly recognize and kill foreign challenges. More than a dozen peer-reviewed science and medical journals have published research on the safety and efficacy of Wellmune WGP over the past several years.

“Wellmune WGP meets the growing demand from food manufacturers and consumers for natural ingredients with real immune health benefits that are backed by credible science and safe for daily consumption,” said Richard G. Mueller, Biothera president and chief executive officer. “A number of major food and beverage companies in the U.S. and worldwide have already expressed significant interest in our technology and Wellmune WGP.”

Wellmune WGP Benefits
Wellmune WGP is:

  • Designed to engage the body’s natural defenses to protect against a wide range of challenges.
  • Proven to activate innate immune cells to more quickly recognize and kill foreign intruders, resulting in a more complete immune response.
  • Demonstrated safe and effective in numerous peer-reviewed clinical and preclinical studies.
  • GRAS-approved (Generally Recognized as Safe) under the provisions of U.S. Food and Drug Administration 21CFR170.35. Wellmune WGP can be taken daily.
  • GMO-free, kosher and nonallergenic.
  • Available as a soluble and insoluble powder for ease of formulation in a wide range of foods and beverages, including clear liquids.
  • Characterized by its pleasant sensory qualities.
  • Protected by Biothera’s intellectual property portfolio that includes more than 40 U.S. patents and patents pending, plus additional filings in more than 20 countries.
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.